Shelter Pharma

Shelter Pharma

42.39
-42.39
(-100.00%)
hide
Key Fundamentals
Add Ratio
Market Cap
69.20 Cr
EPS
6.26
PE Ratio
9.57
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
69.70
52 Week Low
35.70
PB Ratio
1.19
Debt to Equity
0.02
Forecast For
Actual

Company News

View All News
Caret
positive
Shelter Pharma's Board approved conversion of 7,35,000 convertible warrants into equity shares at Rs. 42.25 per share, raising Rs. 2.33 crore from promoters. The conversion increased the company's paid-up share capital from Rs. 15.60 crore to Rs. 16.33 crore, with the new shares ranking pari-passu with existing equity shares.
positive
Shelter Pharma's board approved conversion of 7,35,000 convertible warrants into equity shares at Rs. 42.25 per share, raising Rs. 2.33 crore from three non-promoter investors. The conversion increased the company's paid-up share capital from Rs. 14.86 crore to Rs. 15.60 crore, with the new shares ranking equally with existing equity shares.
neutral
Shelter Pharma Limited confirmed no deviation or variation in the utilization of proceeds from preferential issues of warrants convertible into equity shares for the half-year ended September 30, 2025. The company raised Rs. 9,30,34,500 through the allotment of 88,08,000 warrants at Rs. 42.25 each on August 6, 2025, receiving 25% of the subscription amount. The funds were allocated for working capital (up to 85% of proceeds) and general corporate purposes (up to 15% of proceeds), matching the objects approved in the Extraordinary General Meeting held on July 23, 2025. The remaining 75% amount will be received within 18 months as per ICDR regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,781.50
#1 4,27,441.52
40.68
#1 54,729.00
9.71
#1 10,980
2.89
71.49
6,391.50
1,69,674.24
69.05
9,712.00
18.67
2,191
35.10
47.34
3,689.40
1,24,866.06
58.80
11,539.40
6.99
1,911
30.46
54.89
1,517.30
1,22,560.53
22.73
28,409.50
7.12
5,291
3.71
48.01
1,246.80
1,04,059.64
#1 18.15
33,741.20
16.73
5,725
-0.38
53.56
926.45
93,222.55
18.56
23,511.00
18.55
4,615
34.60
33.23
2,033.00
92,858.19
21.34
22,909.50
13.74
3,306
#1 72.75
58.77
2,240.40
92,474.41
52.05
12,744.20
#1 20.90
2,007
-21.05
32.96
1,209.70
70,259.57
20.70
32,345.60
9.43
3,484
3.81
63.26
5,692.00
68,056.40
28.29
13,458.30
3.70
2,216
10.98
60.35
Growth Rate
Revenue Growth
26.75 %
Net Income Growth
16.13 %
Cash Flow Change
379.59 %
ROE
-2.14 %
ROCE
-1.88 %
EBITDA Margin (Avg.)
-7.19 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
30
23
30
36
40
51
0
Expenses
30
22
27
28
32
41
0
EBITDA
0
0
3
8
9
10
0
Operating Profit %
1 %
1 %
10 %
22 %
21 %
20 %
0 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
3
7
8
10
0
Tax
0
0
1
2
2
2
0
Net Profit
0
0
2
5
6
7
0
EPS in ₹
1.77
0.88
42.54
6.72
5.36
6.26
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
11
10
13
21
38
48
Fixed Assets
2
2
2
2
4
6
Current Assets
8
8
10
19
30
33
Capital Work in Progress
0
0
1
0
0
0
Investments
0
0
0
0
0
0
Other Assets
9
9
11
20
34
42
Total Liabilities
11
10
13
21
38
48
Current Liabilities
4
3
4
6
2
5
Non Current Liabilities
0
0
0
1
1
1
Total Equity
7
7
9
15
36
43
Reserve & Surplus
7
7
8
7
24
31
Share Capital
1
1
1
8
12
12

Cash Flow

Cash Flow
2017
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
0
5
-2
Investing Activities
0
0
0
-1
0
-4
-7
Operating Activities
0
-0
-0
1
0
-2
6
Financing Activities
0
0
1
0
0
11
0

Share Holding

% Holding
Aug 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Aug 2025
Sept 2025
Oct 2025
Promoter
56.89 %
56.89 %
56.89 %
54.97 %
52.32 %
52.32 %
52.32 %
46.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.22 %
30.18 %
30.23 %
40.12 %
43.24 %
42.69 %
42.82 %
49.25 %
Others
13.89 %
12.93 %
12.88 %
4.91 %
4.44 %
4.99 %
4.86 %
3.84 %
No of Share Holders
1,165
836
868
1,119
1,153
1,109
1,094
1,094

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Sept 2024 DIVIDEND Dividend
₹ 0.33 /share
23 Sept 2024 46.97 48.21
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 46.97 47.50
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 46.88 47.15
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 38.00 39.50
23 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
23 Jul 2025 39.60 43.97
23 Sept 2025 DIVIDEND Dividend
₹ 0.35 /share
23 Sept 2025 45.00 43.27
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 45.00 44.00
10 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Nov 2025 41.50 41.86

Announcements

Announcement under Regulation 30 (LODR)-Conversion of Securities3 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday November 17 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only) 3 days ago
Announcement under Regulation 30 (LODR)-Allotment5 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 15 2025 Considered And Approved The Conversion Of 735000 Warrants Into 735000 Equity Shares Of Face Value Of Rs. 10/- (Rupees Ten Only)5 days ago
Intimation With Regards To Shelter Pharma Received ISO 22000:2018 Certification10 days ago
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 10, 2025
Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025Nov 10, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 10 November 2025 And Submission Of The Unaudited Financial Results And Limited Review Report On Financial Result For The Half Year Ended On 30Th September 2025Nov 10, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 06, 2025
Board Meeting Intimation for Board Meeting Intimation For Board Meeting To Be Held On 10Th November 2025Nov 05, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 03, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 16, 2025
Board Meeting Outcome for 861000 Equity Shares Allotted Pursuant To Conversion Of Warrants Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 03, 2025
Board Meeting Outcome for 1128000 Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.Oct 03, 2025
Announcement under Regulation 30 (LODR)-Conversion of SecuritiesOct 01, 2025
Board Meeting Outcome for Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.Oct 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 29, 2025
Intimation Of Shelter PharmaS Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing RegulationsSep 23, 2025
Shelter Pharma Limited Embarks On Sustainability Journey With The Installation Of A 15 KW Solar Power Plant At Its Factory Situated At Shelter Nagar Nr. S. T. Bus Stand Himmatnagar Gujarat India 383001Sep 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Notice Of 18Th Annual General MeetingSep 06, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 02, 2025
Approved Tuesday 23Rd September 2025 As The Cut-Off Date As For The Purpose Of E-Voting And Dividend Entitlement. Dividend Shall Be Payable To Equity Shareholder; Whose Names Stand Registered On The CompanyS Register Of Members As Beneficial Owners As ASep 02, 2025
To Close The Register Of Members Of The Company From Wednesday 24Th September 2025 To Tuesday 30Th September 2025 (Both Days Inclusive) For The Purpose Of Payment Of Dividend And Annual General Meeting.Sep 02, 2025
The 18Th Annual General Meeting Of The Company Will Be Held On Tuesday 30Th September 2025 At 10:00 A.M. At Registered Office Of The Company At Shelter Nagar Nr. S. T. Bus Stand Himmatnagar GJ 383001 IN Gujarat For The Financial Year Ended On 31St March 2Sep 02, 2025
Corporate Action-Board approves DividendSep 02, 2025
Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday 02Nd September 2025Sep 02, 2025
Board Meeting Intimation for Intimation Regarding Meeting Of The Board Of Directors Of The Company That Will Be Held On Tuesday 02Nd September 2025.Aug 27, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 20, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Selection Of Veterinary Products For Supply To AMULAug 08, 2025
Announcement under Regulation 30 (LODR)-AllotmentAug 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 06Th August 2025 For Allotment Of 8808000 WarrantsAug 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJul 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 12, 2025
Intimation Of Shelter PharmaS Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing RegulationsJul 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2025
Submission Of Notice Of 01/2025-26 Extra-Ordinary General Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 30, 2025
Convening Of 01/2025-26 Extra-Ordinary General Meeting (EGM) On Wednesday 23Rd July 2025 At 10:00 A.M At The Registered Office Of The Company. The Notice Of The Said EGM And Other Related Details Shall Be Submitted To The Stock Exchanges In Due Course In Jun 26, 2025
Fixed Thursday 17Th July 2025 As The Record Date For The Purpose Of Determining The Eligibility Of The Members To Attend And Vote (Including Through E-Voting) At The 01/2025-26 Extraordinary General Meeting (EGM) Of The Company Scheduled To Be Held On WedJun 26, 2025
Announcement under Regulation 30 (LODR)-Preferential IssueJun 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today On Thursday 26Th June 2025 And Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015Jun 26, 2025

Technical Indicators

RSI(14)
Neutral
49.54
ATR(14)
Less Volatile
1.89
STOCH(9,6)
Neutral
22.00
STOCH RSI(14)
Neutral
38.64
MACD(12,26)
Bullish
0.07
ADX(14)
Weak Trend
21.14
UO(9)
Bearish
37.11
ROC(12)
Uptrend And Accelerating
2.14
WillR(14)
Neutral
-63.29